Gagnon Securities LLC Pacira Bio Sciences, Inc. Transaction History

Gagnon Securities LLC

$416 Million
Q1 2024

A detailed history of Gagnon Securities LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gagnon Securities LLC holds 548,968 shares of PCRX stock, worth $15.7 Million. This represents 3.85% of its overall portfolio holdings.

Number of Shares

548,968

Previous 545,579 0.62%

Holding current value

$15.7 Million

Previous $18.4 Million 12.86%

% of portfolio

3.85%

Previous 4.44%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.7 - $35.48 $93,875 - $120,241	3,389 Added 0.62%	548,968 $16 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $522,452 - $681,053	-19,850 Reduced 3.51%	545,579 $18.4 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $190,829 - $249,359	6,220 Added 1.11%	565,429 $17.3 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $47.5 $90,336 - $118,797	-2,501 Reduced 0.45%	559,209 $22.4 Million
Q1 2023 Apr 10, 2023	SELL	$35.53 - $43.38 $60,578 - $73,962	-1,705 Reduced 0.3%	561,710 $22.9 Million

Q4 2022 Feb 07, 2023	SELL	$38.19 - $57.45 $427,460 - $643,037	-11,193 Reduced 1.95%	563,415 $21.8 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $1.01 Million - $1.17 Million	-19,784 Reduced 3.33%	574,608 $30.6 Million
Q2 2022 Aug 01, 2022	SELL	$51.49 - $81.64 $851,696 - $1.35 Million	-16,541 Reduced 2.71%	594,392 $34.7 Million
Q1 2022 May 09, 2022	SELL	$60.03 - $76.49 $171,505 - $218,531	-2,857 Reduced 0.47%	610,933 $46.6 Million
Q4 2021 Feb 08, 2022	BUY	$47.97 - $62.21 $2.07 Million - $2.68 Million	43,147 Added 7.56%	613,790 $36.9 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $3.9 Million - $4.37 Million	71,310 Added 14.28%	570,643 $32 Million
Q2 2021 Jul 28, 2021	BUY	$59.18 - $69.99 $2.63 Million - $3.11 Million	44,484 Added 9.78%	499,333 $30.3 Million
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $1.18 Million - $1.57 Million	19,894 Added 4.57%	454,849 $31.9 Million
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $468,765 - $615,422	9,288 Added 2.18%	434,955 $26 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $183,246 - $222,138	3,526 Added 0.84%	425,667 $25.6 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $461,445 - $786,105	14,982 Added 3.68%	422,141 $22.2 Million
Q1 2020 May 11, 2020	BUY	$28.4 - $50.7 $603,414 - $1.08 Million	21,247 Added 5.51%	407,159 $13.7 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $53,266 - $68,699	-1,467 Reduced 0.38%	385,912 $17.5 Million
Q3 2019 Nov 08, 2019	BUY	$35.66 - $44.99 $3.88 Million - $4.89 Million	108,766 Added 39.04%	387,379 $14.7 Million
Q2 2019 Aug 12, 2019	BUY	$36.57 - $47.97 $10.2 Million - $13.4 Million	278,613 New	278,613 $12.1 Million

Others Institutions Holding PCRX

# of Institutions

286

Shares Held

48.7M

Call Options Held

156K

Put Options Held

623K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.31B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.

Account

Gagnon Securities LLC Pacira Bio Sciences, Inc. Transaction History